Recent Updates
Recently added Catalysts
LNTH Positive Sentiment

Lantheus to Host Third Quarter 2023 Earnings Conference Call and Webcast on November 2, 2023, at 8:00 a.m. Eastern Time

Thursday, October 19, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Lantheus Holdings, Inc. has announced it will host a conference call and webcast to discuss its third quarter financial and operational results on November 2, 2023, at 8:00 a.m. Eastern Time. The company encourages participants to register in advance to avoid delays. Following the call, a replay will be made available for 30 days on their investor relations webpage. Lantheus is known for its dedication to enhancing patient care through innovative treatments and technologies.
Price reaction · baseline $70.48 (2023-10-18 close) · hit after-hours · clean, no other LNTH news in the window
day 0 close · peak
-1.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • Lantheus is actively engaging with investors through a conference call.
  • The company has a strong commitment to improving patient outcomes.
  • The upcoming earnings call provides an opportunity for transparency about financial results.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+48%
120-day peak, hindsight
Typical move
2%
average across 7 past catalysts
Lead asset
18F-DCFPyL
Phase 3 · Prostate Cancer

Full Press Release Details

BEDFORD, Mass., Oct. 19, 2023 (GLOBE NEWSWIRE) --  Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, November 2, 2023, to discuss its financial and operating results for the third quarter of 2023.
To access the conference call or webcast, participants should register online at https://investor.lantheus.com/news-events/calendar-of-events. To avoid delays, we encourage participants to register fifteen minutes ahead of the scheduled start time.
A replay will be available approximately two hours after completion of the webcast and will be archived on the same web page for at least 30 days.
With more than 65 years of experience in delivering life-changing science, Lantheus is committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease. Lantheus is headquartered in Massachusetts and has offices in New Jersey, Canada and Sweden. For more information, visit www.lantheus.com.

Frequently Asked Questions

When is Lantheus' earnings call scheduled?

Lantheus' earnings call is on November 2, 2023, at 8:00 a.m. ET.

How can I access the conference call?

Participants can register online at Lantheus' investor relations website.

Will there be a replay of the webcast?

Yes, a replay will be available about two hours after the webcast.

How long will the webcast replay be available?

The replay will be archived for at least 30 days.

What is Lantheus' focus in healthcare?

Lantheus focuses on diagnostics, radiotherapeutics, and AI to enhance patient outcomes.

ShareAdd on Google
Tags: LNTH Viatris Investor Conferences Healthcare Lantheus 2023 earnings call financial results conference call
Last updated: Oct 19, 2023

Biotech snapshot

Cash runway
$593M liquidity · $0M/mo burn
Low dilution risk
Lead asset
18F-DCFPyLPhase 3
Prostate Cancer →

Catalyst track record

+48%
best trade around LNTH's most recent catalyst

Peak hindsight return over a 120-day window, across 7 tracked FDA/PDUFA catalysts for LNTH.

See every catalyst's timing & PoA →